These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 17938296)
21. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy. Ayyanathan S; Hersh D; Coplan NL; Garratt K Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578 [TBL] [Abstract][Full Text] [Related]
23. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL; Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853 [TBL] [Abstract][Full Text] [Related]
27. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study. Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312 [TBL] [Abstract][Full Text] [Related]
28. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions. Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862 [TBL] [Abstract][Full Text] [Related]
29. Pathology of drug-eluting stents: implications for coronary intervention. Finn AV; Nakazawa G; Virmani R Indian Heart J; 2007; 59(2 Suppl B):B41-9. PubMed ID: 19153436 [TBL] [Abstract][Full Text] [Related]
30. Long-term clinical effects of magnetic resonance imaging in patients with coronary artery stent implantation. Kaya MG; Okyay K; Yazici H; Sen N; Tavil Y; Turkoglu S; Timurkaynak T; Ozdemir M; Cemri M; Yalcin R; Cengel A Coron Artery Dis; 2009 Mar; 20(2):138-42. PubMed ID: 19247183 [TBL] [Abstract][Full Text] [Related]
34. Drug-eluting stent for long coronary artery disease. Park SJ; Kim YH Indian Heart J; 2008; 60(6):519-23. PubMed ID: 19276489 [No Abstract] [Full Text] [Related]
35. A critical appraisal of the safety and efficacy of drug-eluting stents. Maluenda G; Lemesle G; Waksman R Clin Pharmacol Ther; 2009 May; 85(5):474-80. PubMed ID: 19279567 [TBL] [Abstract][Full Text] [Related]
36. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents. Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823 [TBL] [Abstract][Full Text] [Related]
37. Greyscale intravascular ultrasound and IVUS-radiofrequency tissue characterisation to improve understanding of the mechanisms of coronary stent thrombosis in drug-eluting stents. Garcia-Garcia HM; Gonzalo N; Kukreja N; Alfonso F EuroIntervention; 2008 Aug; 4 Suppl C():C33-8. PubMed ID: 19202689 [TBL] [Abstract][Full Text] [Related]
38. Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations. Paradis JM; Ducrocq G; Tanguay JF Minerva Cardioangiol; 2008 Feb; 56(1):139-54. PubMed ID: 18432176 [TBL] [Abstract][Full Text] [Related]
39. Drug-eluting coronary stents: many meta-analyses, little benefit. Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727 [TBL] [Abstract][Full Text] [Related]
40. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents. Kitoga M; Pasquet A; Preumont V; Kefer J; Hermans MP; Vanoverschelde JL; Buysschaert M Diabetes Metab; 2008 Feb; 34(1):62-7. PubMed ID: 18069029 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]